Stock OCGN OCUGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Ocugen, Inc.

Equities

OCGN

US67577C1053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.73 USD +8.81% Intraday chart for Ocugen, Inc. -1.14% +200.87%
May. 31 Sector Update: Health Care Stocks Advance Friday Afternoon MT
May. 31 Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
PR
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
GL
Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN
PR
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
NE
OCUGEN SET TO JOIN RUSSELL 3000 INDEX EFFECTIVE JUNE 28, 2024
AQ
Ocugen to Present at BIO International Convention 2024
GL
Ocugen Set to Join Russell 3000® Index Effective June 28, 2024
GL
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
BU
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
PR
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm
PR
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
PR
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
PR
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
PR
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
PR
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
BU
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
BU
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
BU
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
GL
ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
PR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OCGN Stock
  4. News Ocugen, Inc.
  5. Press Releases